Fusion transcripts in normal human cortex increase with age and show distinct genomic features for single cells and tissues by Mehani, B et al.
F u sion  t r a n sc rip t s  in no r m al  
h u m a n  co r t ex inc r e a s e  wi th  a g e  
a n d  s how  dis tinc t  g e no mic  
fea t u r e s  for  single  c ells  a n d  
tis s u e s
M e h a ni, B, N a r t a ,  K, Pa ul, D, Raj, A, Kum ar, D, S h a r m a,  A, Kau r a ni,  
L, N ay ak, S, Das h,  D, S u ri,  A, S a rk ar, C a n d  M uk ho p a d hy ay, A
h t t p://dx.doi.o r g/10.1 0 3 8/s4 1 5 9 8-0 2 0-5 8 1 6 5-6
Tit l e F u sion  t r a n s c rip t s  in no r m al  h u m a n  co r t ex inc r e a s e  wi t h  
a g e  a n d  s how  dis tinc t  g e no mic  fea t u r e s  for  single  c ells  a n d  
ti s s u e s
Aut h or s M e h a ni, B, N a r t a ,  K, Paul, D, Raj, A, Kum ar, D, S h a r m a,  A, 
Kau r a ni, L, N ayak,  S, Das h,  D, S u ri,  A, S a rk ar, C a n d  
M uk ho p a d hy ay, A
Typ e Article
U RL This  ve r sion  is available  a t :  
h t t p://usir.s alfor d. ac.uk/id/e p rin t/56 1 7 9/
P u bl i s h e d  D a t e 2 0 2 0
U SIR is a  digi t al collec tion  of t h e  r e s e a r c h  ou t p u t  of t h e  U nive r si ty of S alford.  
Whe r e  copyrigh t  p e r mi t s,  full t ex t  m a t e ri al  h eld  in t h e  r e posi to ry is m a d e  
fre ely availabl e  online  a n d  c a n  b e  r e a d ,  dow nloa d e d  a n d  copied  for  no n-
co m m e rcial p riva t e  s t u dy o r  r e s e a r c h  p u r pos e s .  Ple a s e  c h e ck  t h e  m a n u sc rip t  
for  a ny fu r t h e r  copyrig h t  r e s t ric tions.
For  m o r e  info r m a tion,  including  ou r  policy a n d  s u b mission  p roc e d u r e ,  ple a s e
con t ac t  t h e  Re posi to ry Tea m  a t :  u si r@s alford. ac.uk .
1Scientific RepoRtS |         (2020) 10:1368  | https://doi.org/10.1038/s41598-020-58165-6
www.nature.com/scientificreports
fusion transcripts in normal human 
cortex increase with age and show 
distinct genomic features for single 
cells and tissues
Bharati Mehani  1,2, Kiran narta1,2, Deepanjan paul1,2, Anurag Raj  2,3, Deepak Kumar1,4, 
Anchal Sharma1,2, Lalit Kaurani1, Subhashree nayak5, Debasis Dash2,3, Ashish Suri6, 
chitra Sarkar5 & Arijit Mukhopadhyay2,7*
Fusion transcripts can contribute to diversity of molecular networks in the human cortex. In this study, 
we explored the occurrence of fusion transcripts in normal human cortex along with single neurons 
and astrocytes. We identified 1305 non-redundant fusion events from 388 transcriptomes representing 
59 human cortices and 329 single cells. Our results indicate while the majority of fusion transcripts 
in human cortex are intra-chromosomal (85%), events found in single neurons and astrocytes 
were primarily inter-chromosomal (80%). The number of fusions in single neurons was significantly 
higher than that in single astrocytes (p < 0.05), indicating fusion as a possible contributor towards 
transcriptome diversity in neuronal cells. The identified fusions were largely private and 4 specific 
recurring events were found both in cortex and in single neurons but not in astrocytes. We found a 
significant increase in the number of fusion transcripts in human brain with increasing age both in single 
cells and whole cortex (p < 0.0005 and < 0.005, respectively). This is likely one of the many possible 
contributors for the inherent plasticity of the adult brain. The fusion transcripts in fetal brain were 
enriched for genes for long-term depression; while those in adult brain involved genes enriched for 
long-term potentiation pathways. Our findings demonstrate fusion transcripts are naturally occurring 
phenomenon spanning across the health-disease continuum, and likely contribute to the diverse 
molecular network of human brain.
Biological systems utilize their built-in flexibility to respond to unknown situations that challenge their ‘fitness’ 
to adapt and respond. This flexibility usually increases with increased complexity and diversity of more recently 
evolved species. Human biology, in particular of the human brain, is one of the most diverse natural systems. At a 
molecular level, this flexibility is created and maintained by contributions from all layers of information - namely, 
DNA, RNA and Proteins, usually following an increasing order of diversity. We have earlier reported the extent 
of DNA level diversity and its possible role due to somatic single nucleotide variations in normal human brain1. 
Earlier studies have reported wide variety of DNA level diversity in neuron rich regions of normal human brain - 
ranging from whole chromosomes2,3, large-scale retro transpositions4,5, and copy number variations at the single 
neuron level6. We have also shown the diversity in the non-coding RNA of human brain attributed through the 
RNA editing mechanisms in miRNAs and their possible role in biological outcome7. In this study, we embarked 
on investigation of fusion transcripts in human brain - another possible mechanism by which the transcriptome 
can contribute to the diversity of complex systems.
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Fusion transcripts have sequences from two or more genes, unlike conventionally spliced mRNA isoforms8,9. 
These fusions may arise at the genomic level by various structural rearrangements like deletion, duplication, 
inversion or translocation10 as well as at transcriptomic level by RNA-polymerase read-through11,12, cis- or 
trans-splicing13. Thus, investigation of transcriptomic analysis using massively parallel sequencing strategies pro-
vides an opportunity to capture all fusion transcripts – irrespective of their genomic or transcriptomic origins14,15.
Fusion transcripts and their encoded products were earlier perceived to be an aberration with negative out-
come – owing to their abundance in cancers16–18. A few isolated studies have reported the existence of fusion 
RNAs within the normal human genome19,20.
In this study, we elucidated the landscape of fusion transcripts in the frontal cortex of human brain. For a com-
prehensive understanding, we have explored the transcriptome at the tissue level (cortex) as well as at the level of 
single neurons and astrocytes. Further, we analysed age related changes in fusion transcript of human brain. To 
our knowledge this is the most comprehensive study of fusion transcripts in normal human brain.
Results
Fusion transcripts in frontal cortex show a bias for intra-chromosomal events. We analyzed 
59 whole-transcriptome datasets comprising of 49 prefrontal cortices (public domain) and 10 frontal cortices 
(sequenced in-house). By analyzing ~4.2 billion sequencing reads we identified 88 fusion transcripts representing 
38 non-redundant events (Supplementary Table S1).
We observed an enrichment of intra-chromosomal fusions amongst these events (87%, 33/38; Fig. 1a). Almost 
half of the events (47%, 18/38) were found at least twice, and 5 of them were in minimum 4 samples (Table 1). 
Analysis of the sequence context around the identified break-points revealed, 82% (31/38) of the events were fused 
at the exon boundaries from either one or both parental genes (Fig. 1b), and 91% (28/31) of them retained the 
canonical GT-AG splice sites (Fig. 1c). This indicated that a majority of the fusion transcripts, identified through our 
analysis, was formed by the classical splicing machinery – albeit joining fragments from 2 different mRNAs.
We used the available frontal cortex (FC) samples for experimental validation of the identified fusions. Based 
on the recurrence and supporting reads, 3 selected fusion events were validated using fusion specific PCR fol-
lowed by Sanger sequencing. They include, (i) two recurring events, namely, KANSL1-ARL17A (Fig. 2a) (also 
see later) and RP11-572M11.1-C3ORF17 (Fig. 2b) along with (ii) a private event: MTOR-UBIAD1 (Fig. 2c). 
MTOR-UBIAD1 was further quantified by qPCR and was found to have lower expression (~0.3 fold) with respect 
to MTOR – one of the parent genes (Supplementary Fig. S1).
Fusion transcripts in single cells are rich in inter-chromosomal events. We used single cell tran-
scriptome data from human brain to resolve the tissue level data with increased resolution. For this we considered 
publically available transcriptomic libraries from 131 neurons and 62 astrocytes collected from 7 different healthy 
adult brains. Upon analyzing 500 million reads (minimum 1 million reads per cell, Supplementary Fig. S2), a total 
of 912 non-redundant fusion events were identified (Supplementary Tables S2 and S3).
Interestingly, fusion transcripts identified in single cells demonstrated a clear bias for inter-chromosomal 
events with 82% (749/912) fusions involving genes from two different chromosomes (Fig. 3a) – which was in 
contrast to our findings for the cortex samples. Fusion transcripts from single cells revealed a smaller fraction that 
harbor exonic boundaries from either of the two partner genes (28%, 251/911) and only ~33% (82/251) of them 
harbor the canonical GT-AG site (Supplementary Fig. S3).
Three recurring fusions were identified in single neurons which were also found to recur in cortex samples 
(Supplementary Fig. S4). In contrast, single astrocytes had all private events and none of them were common with 
the events found in the cortex samples.
Surprisingly, we found significantly higher (one tailed Wilcoxon p value < 0.005) number of fusions in neu-
rons when compared to the astrocytes (Fig. 3b). Simultaneously, expression analysis revealed that 87% of the 
genes harboring fusion in neurons, have a considerable expression (FPKM > 1) in astrocytes (Supplementary 
Fig. S5A) and only 27% (462/1726) of them were differentially expressed. The expression analysis indicates the 
difference in fusion load is not due to absence of the expression of genes that are involved in fusion.
Adult brain harbor more fusion transcripts than fetal brain. To ascertain any association between 
the fusion burden and aging brain we considered another data set encompassing brain transcriptomes from two 
distinct age groups. Towards this we analyzed a total of ~2 billion RNA sequencing reads from Dorso Lateral 
Frontal Cortices (DLFC) derived from 16 adult and 8 newborns together with 131 and 110 single neurons derived 
from 7 adult and 5 fetal brains respectively. We identified 63 unique fusions in 16 adult brains while 10 fusions in 
fetal brain. Similarly, 724 fusion events were observed in adult neurons and 302 in fetal neurons (Supplementary 
Tables S3–S6).
Strikingly, fusion transcripts were found to be higher (~2 times) in adult brain compared to the fetal brain, 
be it a cell or a tissue (one tailed Wilcoxon p value < 0.05) (Fig. 4a,b). Concurrently, expression analysis demon-
strated that 88% of the genes harboring fusion in adults also have a considerable expression (FPKM > 1) in fetal 
brain (Supplementary Fig. S5B,C), with only 17% (287/1726) of them were differentially expressed between them.
To know the functional significance of these genes that undergo fusion, we also performed their enrichment 
analysis using GSEA. Genes harboring fusion demonstrated a significant enrichment for the long-term poten-
tiation pathway in adults while in fetal there was a significant representation for long-term depression pathway 
(both with p value < 0.00001) (Fig. 4c,d).
Translational ability of fusion transcripts. To test the translational ability of these fusion events we 
performed in-silico translation around the junction by translating them into six reading frames. These putative 
fusion peptides were first subjected to in-silico digestion with trypsin followed by MS identification. We used 
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publically available MS/MS data from human cortex to map our digested peptides and identified 214 putative 
translated junctions. Among them 23% (49/214) were found in multiple proteomes (Supplementary Table S7) and 
15% (31/214) retained the reading frame from either of their parent gene (Table 2). One of the best hits was the 
GDI2-FAM208B junction peptide which retained the reading frame from both of its parent genes.
Topology of the chromosomes inside a cell and fusion transcripts. To test if fusions can occur 
between spatially proximal regions of the genome, we also performed an unbiased chromatin interaction map-
ping. To test the same, we used ENCODE Hi-C data from 10 different human cell lines. This set of analysis 
led us to identify 32190 significant genome wide chromatin interactions (Z score > 1.96) reported in at least 2 
cell lines at a 40 kb resolution (Fig. 5a and Supplementary Table S8). This set of analysis demonstrated frequent 
cis-chromatin interactions within chr 17 and maximum number of trans-interactions between chr 1 and chr 16 
(Fig. 5b).
Figure 1. Fusion transcripts identified in human cortex. (a) Circos plot representing 38 unique fusions, where 
periphery of the plot represents different chromosomes and links denote fusion events. Red links are inter-
chromosomal event involving genes from two different chromosomes and links that are in green are intra-
chromosomal fusion between genes from same chromosome. (b) Percentage of fusion breakpoints containing 
exon boundaries from one, both or neither of their parent genes. (c) Percentages of fusion transcripts that use 
canonical splice site signature GT-AG, CT-AC, or another donor-acceptor sequential preference in brain tissues. 
(d) Preferred sequences around fusion breakpoint matching with the signature for canonical splicing.
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By comparing fusion breakpoints with the Hi-C interaction maps of three-dimensional chromosome confor-
mation led us to detect nine fusion partners located in broad chromatin domains that are spatially proximal in 
normal cell nuclei (Table 3). These events involve an interesting inter-chromosomal ENSG00000227733-HYDIN 
fusion involving ENSG00000227733 and HYDIN genes from chromosome 1 and 16 respectively. 
ENSG00000227733-HYDIN fusion was one of the recurring events identified in both single neurons as well as 
in brain tissues indicating its neuronal preference. Co-occurrence of Hi-C interaction map around its breakpoint 
suggests spatial proximity could be an important trigger to facilitate this fusion between the two distantly located 
genomic loci.
KANSL1-ARL17A transcript and its status in GBM. KANSL1-ARL17 fusion was one of the most recur-
ring events comprising of first three exons from KANSL1 and last three exons from ARL17. It was identified 
in ~20% (12/59) of normal brain tissues (Supplementary Table S1). CNV signature around its junction from 
our analysis signifies its genomic origin and it is also a well-documented DNA level event in multiple cancers 
(Table 4).
To test the status of this particular fusion in disease condition we used a most malignant brain tumor i.e. 
Glioblastoma multiforme (GBM). By performing junction specific PCR, we validated the same event in 7 out of 













KANSL1* ARL17A* chr17 44171925 chr17 44430295 10 GT-AG yes yes
KANSL1* ARL17A* chr17 44171925 chr17 44648234 9 GT-AG yes yes
ENSG00000212127* PRH1-PRR4* chr12 11126253 chr12 11001005 5 GT-AG yes yes
ENSG00000227733* HYDIN* chr1 146126403 chr16 71196632 4 GT-AG yes yes
FAM78B ENSG00000229588 chr1 166135290 chr1 166304564 4 GT-AG no yes
FLJ39739 NBPF9 chr1 147917467 chr1 144676872 3 CC-TA no no
CCDC7* C10orf68* chr10 32854485 chr10 32873231 3 CT-AC yes yes
ABLIM1 ENSG00000228484 chr10 116361719 chr10 116527819 3 CT-AC yes no
LOC100129961* ENSG00000224043* chr2 135635089 chr2 135493150 3 GT-AG yes yes
ENSG00000225065* NCOA6* chr20 33302393 chr20 33303168 3 GT-AG yes yes
ENSG00000243795 C3orf17 chr3 112862700 chr3 112738552 3 CT-AC no yes
ENSG00000236537* TULP4* chr6 158733082 chr6 158735299 3 CT-AC yes yes
LOC729852 ENSG00000233108 chr7 7841373 chr7 8007329 3 GT-AG yes no
ENSG00000218328 KAZN chr1 14507086 chr1 14925478 2 GT-AG yes no
PDE4DIP FLJ39739 chr1 145013720 chr1 147931723 2 CT-AC no yes
CCDC7* C10orf68* chr10 32832227 chr10 32873231 2 CT-AC yes yes
HSPA12A ENO4 chr10 118466795 chr10 118609076 2 CT-AC yes no
ENSG00000231121* NAV3* chr12 77966045 chr12 78334098 2 GT-AG yes yes
ENSG00000230021 PCBD2 chr1 564469 chr5 134261453 1 AC-TG no no
ENSG00000198744 DHFR chr1 570067 chr5 79946838 1 GC-CA no no
MTOR UBIAD1 chr1 11316632 chr1 11334116 1 CT-AC no yes
ENSG00000231485* JAK1* chr1 65532310 chr1 65352023 1 GT-AG yes yes
PFKFB3* LOC399715* chr10 6268327 chr10 6368508 1 GT-AG yes yes
ENSG00000249456 ZRANB1 chr10 126628942 chr10 126631875 1 CT-AC no yes
ALG1L9P FAM66C chr11 71518527 chr12 8346798 1 GT-AG no yes
OPCML* NTM* chr11 132812820 chr11 132081915 1 GT-AG yes yes
ENSG00000245482 ALG10B chr12 34185072 chr12 38720271 1 CT-AA no no
ACAD10 MAPKAPK5 chr12 112182444 chr12 112308981 1 AA-CT yes yes
PSMC1 ENSG00000205533 chr14 90738533 chr14 90739625 1 AG-CC no no
ENSG00000186031* FMN1* chr15 33445248 chr15 33300275 1 GT-AG yes yes
LRRK1 CHSY1 chr15 101590983 chr15 101775286 1 CT-AC no yes
THRB THRB-AS1 chr3 24378861 chr3 24536623 1 CT-AC yes no
ENSG00000249598 SDHAP1 chr3 195685882 chr3 195686956 1 GT-AG no yes
ENSG00000250859 HNRNPK chr5 126847434 chr9 86585718 1 AT-AG no yes
ENSG00000236537* TULP4* chr6 158703294 chr6 158735299 1 CT-AC yes yes
CPQ TSPYL5 chr8 97919555 chr8 98287867 1 CT-AC no no
CLIC2 ENSG00000224216 chrX 154563678 chrX 154564556 1 TA-GG yes yes
TTTY14 NCRNA00185 chrY 21239153 chrY 21039090 1 GT-AG no no
Table 1. Fusion transcripts identified in 59 brain samples. The asterisk (*) represents events retaining exon 
boundaries from both of its partner genes.
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9 (78%) GBM samples and further confirmed it by Sanger sequencing (Fig. 6a and Supplementary Fig. S6). The 
large difference in frequency of this fusion event in GBM and normal brain led us to investigate the 17q21.31 
locus, which harbours both the parent genes (KANSL1 and ARL17).
17q21.31 is a cryptic locus and known to have two different haplotypes along with their subtypes21. H1β 
duplication is the only subtype capable to produce KANSL1-ARL17 fusion. We confirmed H1β duplication in our 
in-house normal brain samples which were observed to have an allele frequency of 70%, (7/10) as it was detected 
in the case of GBM samples (Fig. 6b). These results highlight the prominence of H1β duplication in south Asian 
population with an allele frequency close to 70%.
The expression of the KANSL1-ARL17 fusion transcript and its parent genes were also assessed with 
Real-Time PCR between GBM and our in-house normal brain tissues. Interestingly, KANSL1-ARL17 fusion tran-
script was found to be down regulated (5 ×) in GBM while it was up-regulated (5 ×) to the same extent in normal 
brain when compared to its parent gene (KANSL1) (Fig. 6c,d). These results indicate fusion product might have 
different function compared to its parent genes. Likewise, it’s not the presence rather the expression levels of the 
KANSL1-ARL17 fusion can be linked with cancer etiology.
Figure 2. Fusion specific PCR product was run on 2% agarose gel and further confirmed by using Sanger 
sequencing. Validation of (a) KANSL1-ARL17 fusion was validated in FC171, FC151 & FC156 with a product 
size of 239 bp; (b) C3ORF17-RP11-572M11.3 fusion in FC171 & FC202 with a product size of 227 bp and (c) 
mTOR-UBIAD1 fusion in FC171 with a product size of 236 bp. Strategy used to design the fusion specific primer 
is depicted in the Supplementary Fig. S7.
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Discussion
The life span and ‘fitness’ of an organism is the sum of deleterious changes and counteracting repair and main-
tenance mechanisms that trigger in response to stimuli22. This is not only true for whole organisms but also true 
at the levels of tissues, organs and individual cells. Recent surge of next generation sequencing data has revealed 
that in the human brain this diversity is achieved and maintained not only by the inherited set of variations but 
also by the variability introduced de novo at the somatic level for both DNA and RNA23–25. Fusion transcripts are 
one of many possible ways to create and maintain the much needed diversity – especially in post-mitotic cells 
like human neurons. Fusion transcripts are now widely reported in the literature albeit with a bias towards their 
presence and function in diseases – especially for their oncogenic role in human cancers. However, these tran-
scripts can have a big influence on the normal phenotypic outcome. It has been shown for fusion transcripts that 
the fusion event when created at the RNA level provide a growth advantage while the same event resulting from 
a DNA level translocation may lead to cancer13. The underlying explanation for this observation is likely due to 
the obligatory (and hence more) expression of the fusion RNA when it is formed at the DNA level. This suggests 
a functional continuum of the fusion transcripts, where the same events in moderation can provide an advantage 
while an excess is detrimental. The spectrum of fusion transcripts in normal human tissues and to what extent 
they are functionally relevant is an unanswered question. We embarked on this study in an attempt to address this 
issue focused to the normal human brain, particularly the cortex.
Our analysis showed the organization and distribution of the fusion transcripts are unique and dis-
tinct between the tissue and the single cells. At the tissue level we found more recurrence and majority of the 
events formed between two genes residing on the same chromosome. Notably, our analysis has identified 
KANSL1-ARL17 fusion as a recurring event in normal human cortex. Contrasting expression pattern between 
the KANSL1-ARL17 fusion and its parent gene, KANSL1 in GBM compared to the normal brain warrants further 
investigation, as it suggests their potential role in cancer.
On the other hand, the spectrum of fusion transcripts occurring from the single neurons and astrocytes show 
minimal or no recurrence and the vast majority formed by fusion of two transcripts coming from different chro-
mosomes. Recurrence is an important factor to estimate their abundance. In our case, majority of our events were 
non-recurring between cells which might signify their low abundance or they may be false positive generated by 
template switching of reverse transcriptase during RT-PCR26,27 or possibly a mix of both. Further, a complete lack 
of redundancy in the single astrocytes was striking and cannot be explained. Further research on the same source 
of tissue and single cells might be able to shed light on these observations.
We found significantly higher number of fusions in neurons compared to the astrocytes. This observation, 
together with a considerably higher number of fusions in adult brain compared to the newborns – indicate a 
role of fusion transcripts in maintaining required diversity in neurons with restricted regenerative capabilities 
and age-dependent decline in turnover rate of the cells28,29. Genes harboring fusion demonstrated a significant 
Figure 3. Fusion transcripts identified in single cells from adult human brain. (a) Circos plot represents 911 
unique fusions and signifies 82% (749/911) of the identified events are Inter-chromosomal. Here, periphery of 
the plot represents different chromosomes and links denote fusion events. Red links are inter-chromosomal 
event involving genes from two different chromosomes and links that are in green are intra-chromosomal 
fusion between genes from same chromosome. (b) Neurons (blue) harbor significantly higher number of 
fusions compared to astrocytes (red) (one tailed Wilcoxon p value < 10−3 marked by **), where boxplot 
represents number of fusion transcripts identified in each cell. Horizontal axis denotes brain cells while vertical 
axis represents number of fusion transcripts normalized with total data generated in that cell.
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enrichment for long-term potentiation (LTP) and long-term depression (LTD) pathways in adult and fetal brain 
respectively. Both of these pathways in conjunction provide neuronal synaptic plasticity that undergo age-related 
alterations30–33. Results from our analysis suggest aging leading to a substantial fusion load, which might affect the 
neuronal synaptic function. Evidence for their corresponding junction peptides further support their biological 
relevance. Later on we also identified the inter-chromosomal proximity between ENSG00000227733 and HYDIN 
genes from chromosome 1 and 16, respectively. Co-occurrences of chromatin interaction maps with these fusion 
breakpoints suggest spatial proximity can be one of the possible triggers.
In summary, our genome-wide analysis establish fusion transcripts are naturally occurring phenomenon that 
span the health-disease continuum of the human brain.
Materials and Methods
Sample collection. Frontal cortexes (Grey matter) were procured from post-mortem samples of road acci-
dent victims collected from NIMHANS Brain Bank, Bangalore, India. GBM samples were obtained from AIIMS, 
New Delhi, India. The samples were collected according to the Helsinki Declaration and the ethical review board 
of All India Institute of Medical Sciences, Delhi, India approved the project. Diagnosis and grading of tumor 
samples were done as per 2007 WHO classification. The details of the in-house samples used in the study are pro-
vided in Supplemental Table S9 and S10. Informed consent were obtained from the GBM patients or from their 
family members (next of kin). For the frontal cortex (post-mortem) samples obtained from the brain bank, these 
samples were already covered under the ethical approval obtained by the Brain bank.
RNA isolation, library preparation and RNA sequencing. Total RNA was isolated by using miRvana 
miRNA isolation kit (Ambion, USA) as per the manufacturer’s instructions. RNA Libraries were prepared using 
Illumina’s TruSeq total RNA Sample preparation for 6 FCs and poly-A enriched protocol for rest of the 4 FCs 
following the manufacture’s protocol. Cluster generation and sequencing was done on Illumina HiSeq. 2000 using 
standard Illumina sequencing workflow. The in-house sequencing data is deposited at the sequence read archive 
(SRA ID: SRP045655).
Figure 4. Boxplots represent fusion transcripts are enriched in adult brain compared to the fetal brain. (a) 
In case of single cells, adult neurons (red) harbor significantly higher number of fusions with respect to fetal 
neurons (blue) (one tailed Wilcoxon p value < 10−4 is marked by ***). (b) Similarly, bulk tissue from adult brain 
(red) also demonstrated higher number of fusions compared to fetal (blue) (one tailed Wilcoxon p value < 10−3 
is marked by **) where horizontal axis denotes brain samples while vertical axis represents number of fusion 
transcripts normalized with total data generated in a samples. Pathway enrichment analysis of genes harboring 
fusions has revealed enrichment for genes implicated in processes involved in synaptic plasticity. In the figure 
the horizontal axis shows the negative logarithm of FDR corrected p-value while vertical axis has different 
biological processes. Top biological processes that were significantly enriched in adult brain (c) and fetal brain 
(d) (both from tissue and single cells).
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DNA isolation, library preparation and exome sequencing. DNA isolation was done by using 
Omniprep Genomic DNA isolation kit (G-Biosciences, USA) as per manufacturer’s protocol. Exome capture was 
done using Illumina TruSeq Exome capture kit. 100 base pair paired end sequencing was done using Illumina 
HiSeq. 2000 (Ilumina, USA). The exome sequence data is also deposited at the sequence read archive (SRA ID: 
SRP045655).
Identification of candidate fusion transcripts. Raw data was checked for per base quality score and 
reads having 80% bases with phred quality score 30 and greater were only be considered for downstream anal-
ysis. Fusion transcripts were identified using the published pipeline34 with the default parameters. Briefly, the 
quality filtered reads were aligned using Tophat (version 2.0.5) against transcriptome (UCSC hg19 annotations) 
and genome (hg19) both with 2 mismatches. Discordant reads were used to identify potential fusion candidates 
using its fusion-search module. Tophat-fusion-post was further used to filter out events supported by minimum 
5 supporting reads. The software and detailed description is available at < https://ccb.jhu.edu/software/tophat/
fusion_tutorial.shtml >. The same pipeline was used for both in-house and publicly available dataset for calling 
fusion transcripts.
Fusion transcripts associated with CNVs. To determine if the origin of the detected fusions were 
genomic, we explored signatures for copy number variation around fusion breakpoint Genome-wide CNV calling 
was performed using two different platforms: exome sequencing and illumina’s 660 quad microarray for 4 out of 
10 FC samples (Supplementary Table S9).
Exome sequencing data analysis and CNV calling. Raw data from exome sequencing was checked for 
per base quality score and reads having 80% bases with phred quality score 30 and greater were carried forward 
for downstream analysis and rest were discarded. Filtered reads were aligned to the reference genome (hg19) 









GDI2 FAM208B IIVQNGKVIGVKSEGENLLRKGGHTEIEPQHF VIGVKSEGENLLR intact intact
ENSG00000225302 HSPA12A AKNKMKCDSRWEIAASETAPTSAYSSPARSLGD WEIAASETAPTSAYSSPAR intact intact
ENSG00000212127 PRH1-PRR4 LPAGTCCIYSRVEVFTDVNYEDFTFTIPGKSQ* LPAGTCCIYSRVEVFTDVNYEDFTFTIPGK intact intact
MAP1B DDX3× EKIERTTKSPSDSGYSYRPCVVYGGADIGQQIR SPSDSGYSYRPCVVYGGADIGQQIR intact intact
YLPM1 ZNF207 MVPPYQGGPPRPPMGMRPPPPLPPPPPVIKPQT PPYQGGPPRPPMGMRPPPPLPPPPPVIKPQT intact intact
KLHL8 SMARCAD1 LLRFYENGELCDVTLKLIESTSTMDGAIAAAL FYENGELCDVTLKLIESTSTMDGAIAAAL intact intact
SLC7A5P2 PTPRD CPVPEEAAKLVACHSVPPPRFTRTPVDQTGVSG LVACHSVPPPRFTR intact intact
CSAD ARHGEF12 CA*WKEMSIPLKSSFLLWQDLICRMAASVKEQS SSFLLWQDLICR intact no
GABRB2 ZNF451 MNIDIASIDMVSEVNMNVTVMITWVPKILQ*E NIDIASIDMVSEVNMNVTVMITWVPK intact no
PPP2R4 NPAP1 IDTSDMNTTPPSKTVILQSGQGLRLALV*ESCF IDTSDMNTTPPSKTVILQSGQGLR intact no
ACAD10 MAPKAPK5 QGDLMTPQFTPYYVAPQGKQAPHMRNKLES*PN QGDLMTPQFTPYYVAPQGKQAPHMR intact no
EIF4G3 FRMPD2 RSILNKLTPQMFNQLMKHLPGARHYSRPPSMLR LTPQMFNQLMKHLPGAR intact no
OPCML NTM KAMDNVTVRQGESATLSISQNCRDFFRYLH**R QGESATLSISQNCRDFFR intact no
MALAT1 MLL2 RCEPPRLAGSPFFLTPTNLPSTISPGLGSLPSK CEPPRLAGSPFFLTPTNLPSTISPGLGSLPSK intact no
WDR6 CBFA2T3 SGPGGVVACLEISAAPSGICVCGVARGLASVRV SGPGGVVACLEISAAPSGICVCGVARGLASVR intact no
WDR48 AATF LFKDKGGPEFSSALKNMNLGGLLLQALLEYWPR GGPEFSSALKNMNLGGLLLQALLEYWPR intact no
GRAMD2 HSP90AA1 PEGLKGEEIKKCGREGVNLWVVEQKLSYT*KKT CGREGVNLWVVEQK intact no
SYNE1 SSBP1 PPKEPMDMEAQLMDCQASETWHINM*KRGKLKR PPKEPMDMEAQLMDCQASETWHINM intact no
NUMB ARHGAP24 YLPGLSKPLPYCEELFYILFSMQVKTHNIDFIN YLPGLSKPLPYCEELFYILFSMQVKTHNIDFIN intact no
SH3PXD2A BCLAF1 MGRASHLVHDMQRLPEDQEALDYFSDKESGKQK ASHLVHDMQRLPEDQEALDYFSDK no intact
ZNF292 ARNT2 SQGLSIQSLRNTIGLLIHIFNKHNDKHKAHLIR SQGLSIQSLRNTIGLLIHIFNK no intact
NCKAP1 KIAA1109 RSIVGMTMYNQATQEIALAADHHSKHEAQRHFL SIVGMTMYNQATQEIALAADHHSK no intact
USP11 ATL2 ARVGENVHCGPAKAGENYEDDDLVNSDEVMKK VGENVHCGPAKAGENYEDDDLVNSDEVMK no intact
DPP6 MLLT3 RRRTWTVSILAWLCTPEKPSKDSREHKSAFKE TWTVSILAWLCTPEKPSKDSR no intact
USP34 DDHD1 MRKCVVQLCQGGWLIGQKMDQGRIIKNTAM*VL CVVQLCQGGWLIGQKMDQGR no intact
FAM185A FBXL13 HCQKNHTAKTSPNSWPTGNITLQSKMGNITVGM TSPNSWPTGNITLQSKMGNITVGM no intact
NMD3 MKLN1 ADDYNCKQC*RLALGSEDGLDFYYSSKQHAQKM LALGSEDGLDFYYSSK no intact
ENSG00000178440 TIMM23 TGEVLRRSYTKGSKVLDTDEFILPTGANKTRG GSKVLDTDEFILPTGANK no intact
ENSG00000147421 PCDH9 QVMKWKASLTAVISSDTLISHPLPLVQPQDEF ASLTAVISSDTLISHPLPLVQPQDEF no intact
GRIA4 ENSG00000234873 LDQ*QKQVTHQGTGQPWSWSWLVLLCPPPRGE QVTHQGTGQPWSWSWLVLLCPPPRGE no intact
FAM226B NAP1L2 SSLFSSPVASMSSSSSSSFTATERNWGGCHSLW SSLFSSPVASMSSSSSSSFTATER no intact
Table 2. Table represents putative translated junction for identified fusions a reading frame of their parent 
genes. Highlighted events are identified in multiple proteomics samples.
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using BWA (version 0.6.1)35 allowing for 2 mismatches. More than 98% percent of the data was aligned to refer-
ence for each sample. Data was also checked for PCR duplicates and the same were removed. Aligned reads were 
used to call CNVs using CoNIFER (version 0.2.2)36 with default parameters.
Genome-wide genotyping and CNV calling. Isolation of the genomic DNA was done using a standard 
salting-out procedure to perform genome-wide genotyping by using the Infinium Human660W-quad BeadChip 
method (Illumina, Inc., San Diego, CA, USA). We used 200 ng of genomic DNA for each sample, in accordance 
with the manufacturer’s guidelines. The raw data files were processed by the GenomeStudio software package. To 
call CNVs, we used the PennCNV algorithm and applied a stringent criterion of at least 10 consecutive probes 
to show altered intensity to qualify as a CNV call. We used a threshold of 0.35 for the standard deviation for logR 
ratio of normalized intensity (LRR) and a threshold of 0.05 for the standard deviation for B allele frequency as 
explained in our earlier study.
In order to confirm their genomic evidences for fusion events, we overlaid CNV coordinates obtained from 
above analysis with fusion breakpoints ( ± 500 Kb).
Figure 5. Spatial proximity might be a possible trigger for fusion transcripts. (a) Chromatin interaction map 
identified in 10 human cell lines. Horizontal axis in the plot represents different cell lines and vertical axis 
represents number of chromatin interaction identified in each cell line at 40 Kb resolutions. Blue bars represent 
raw numbers of interactions while that are in red are significant interaction identified with Z score > 1.96 in 
each cell line. (b) Chromosome pairs assisting chromatin interactions and their numbers. Horizontal axis 
represents different chromosome pairs and vertical axis represents number of trans-interactions identified.
Fusion_Pair Fusion breakpoint1 Fusion breakpoint2 Chromatin Interacting locus1 Chromatin Interacting locus2
Chromatin Interaction 
identified in cell line
ENSG00000249456_ZRANB1 chr10:126631875 chr10:126628942 chr10:126640000-126680000 chr10:126600000-126640000 A549, NCI-H460, RPMI-7951, T47D
ZFYVE9_ENSG00000154222 chr1:52815403 chr1:52805352 chr1:52800000-52840000 chr1:52760000-52800000 A549, RPMI-7951, SK-MEL-5, T47D
ENO2_ATN1 chr12:7033739 chr12:7031013 chr12:7040000-7080000 chr12:7000000-7040000 A549, RPMI-7951, SK-MEL-5, G401
ENSG00000225065_NCOA6 chr20:33303168 chr20:33302393 chr20:33320000-33360000 chr20:33280000-33320000 NCI-H460, RPMI-7951, T47D, G401
FAM177A1_PPP2R3C chr14:35557754 chr14:35548998 chr14:35560000-35600000 chr14:35520000-35560000 A549, NCI-H460, G401
ENSG00000227733_HYDIN chr1: 146126403 chr16:71196632 chr1:146100000-146140000 chr16:71160000-71200000 NCI-H460, T47D, G401
GDI2_FAM208B chr10:5798575 chr10:5815804 chr10:5800000-5840000 chr10:5760000-5800000 A549, Caki2
SLC7A6_SLC7A6OS chr16:68338040 chr16:68333926 chr16:68320000-68360000 chr16:68280000-68320000 A549, RPMI-7951
RENBP_SSR4 chrX:153062912 chrX:153208306 chrX:153160000-153200000 chrX:153080000-153120000 A549, SK-N-MC
Table 3. Fusion partners that are also in physical proximity.
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Sequence enrichment around fusion transcripts. Nucleotide sequences extracted from 50 bases 
up-stream (from 5’ gene) and down-stream (from 3’ gene) around the fusion breakpoint were tested for any 
sequence preference. This part of analysis was performed using an in-house Perl script along with an online tool 
WebLogo to calculate the frequency of each base around the junction. (http://weblogo.berkeley.edu/logo.cgi).
Chromosome proximity and fusion transcripts. To determine the chromosome proximity we used 
Hi-C data from ENCODE phase 3 experiments for ten different cell lines as explained in Supplementary Table S9. 
Paired-end Hi-C sequencing data were mapped and curated using a published pipeline HiCUP37 (v0.5.8) and 
Bowtie38 (v2.2.6). All sequencing data was mapped to hg19 reference genome at a resolution of 40 kb. A di-tag 





Gene A Gene B
Chr 
Gene B Cord Gene B chr CNV satrt CNV end CNV state CNV data source
156 fc KANSL1 chr17 44171925 ARL17A chr17 44430295 chr17 44757175 44782177 state2,cn = 1 660quad microarray
156 fc KANSL1 chr17 44171925 ARL17A chr17 44648234 chr17 44757175 44782177 state2,cn = 1 660quad microarray
171 fc MTOR chr1 11316632 UBIAD1 chr1 11334116 chr1 12057354 12062160 dup Exome Sequencing
Table 4. Fusion transcripts having CNV signature around their breakpoints.
Figure 6. Validation of KANSL1-ARL17 fusion in 7/9 GBM. Fusion specific PCR products (239 bp) were ran on 
2% gel with 100 bp ladder and further confirmed by Sanger sequencing. Lower panel denotes a representative 
electropherogram generated by using cDNA from GBM_8163 which was ran on lane 4 of the agarose gel. Rest 
other electropherograms are shown in the supplementary file as Supplementary Fig. S6. (b) Confirmation of H1 
β duplication haplotype in 6/10 in-house samples (FC). PCR products (307 bp) were run on 2% gel with 100 bp 
ladder. Relative expression of fusion transcript along with its parent genes was checked in GBM compared to 
controls. We performed real time PCR using (c) KANSL1-ARL17 fusion, (d) KANSL1 primers with cDNAs from 
6 in-house normal brains along with 6 GBM samples. In both the boxplots, vertical axis represents Log2ΔCt 
calculated using the expression of B2M. We also performed the same set of experiment using fusion specific 
primers for ARL17 and depicted in the Supplementary Fig. S8. Strategy used to design the fusion specific primer 
is depicted in the Supplementary Fig. S7.
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to check if there is any association of chromosomal proximity with fusion transcripts, we overlaid the identified 
chromatin map with these fusion breakpoints.
In-silico translation and proteomics data analysis. To check the translational evidence for identi-
fied fusions, MS/MS Spectral datasets from human cortex were considered from PRIDE projects PXD000263, 
PXD004076, PXD004987, PXD005629 and PXD002775. These were downloaded from the PRIDE repository 
and were searched against the six frame translated database using OMSSA39 and X!Tandem40,41 in integrated 
transcriptomic-proteomic pipeline EuGenoSuite42.
We performed in-silico trypsin digestion for our probable peptides with one miss-matched site. Further 
parameters involve 20 ppm precursor ion tolerance; 0.5 Da product ion tolerance; carbamidomethylation of 
cysteine as fixed modification; and oxidation of methionine and peptide N-terminal acetylation were used as 
variable modifications. Stringent FDR threshold of ≤ 1% was applied to the resulting PSMs and junction specific 
peptides were identified using a customized Perl script. Reading frames for these filtered hits were further con-
firmed by again mapping them with human proteome (RefSeq GRCh37.p13) using stand-alone BLAST tool43.
Gene and pathway enrichment analysis. To understand the functional significance of genes harbor-
ing fusions, pathway analysis was performed using Gene Set Enrichment Analysis (GSEA)44,45. We applied gene 
ontology enrichment analysis using KEGG pathways to generate gene clusters enriching similar biological pro-
cesses. Gene cluster and their corresponding pathways with highest enrichment score and FDR q-value < 0.05 
were only considered for literature mining.
Statistical analysis. Differential numbers of fusion transcripts between groups of samples were screened 
out using Wilcoxon rank-sum test. P < 0.05 was considered as statistically significant. Inter-individual differences 
between cells and tissues were quantified by using Principal Component Analyss and were performed in R plat-
form (http://www.rproject.org) using rlog-transformed read count from whole transcriptome.
Validation and quantification. cDNA conversion of the extracted RNA (1 micro-gram) was done using 
High-Capacity cDNA Reverse transcription kit (Thermo Fischer Scientific) as per manufacturer’s protocol in a 
reaction volume of 20 µl. To target fusion junction we designed fusion specific primers by using Primer3 software 
(http://frodo.wi.mit.edu/primer3/) and their genomic locations were confirmed by UCSC’s In-silico PCR option. 
The list of primers used in this study is provided in Supplementary Table S10. These primers were subjected to 
PCR and to amplify the junction specific PCR product. Quantitative PCR (qPCR) was carried out using SYBR 
Green master-mix (KAPA) on Roche LC480 system using primers detailed in Supplementary Table S10. Fusion 
expression was determined using the delta-delta CT method46 and using B2M as the house-keeping gene.
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